Skip to content

News & calendar

news: as of 2026-10-10
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Mon · 12 Oct · today

Tue · 13 Oct

Behind

published · newest first

Wed · 15 Jul

funding

11:01
Google News: ENGIE

Engie Brasil's share offering raises $1.7 billion

Engie Brasil raised $1.7 billion through a share offering.

Markets open original ↗

earnings

10:22
Google News: Genmab A/S

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

Genmab announced its Darzalex net sales figures for the second quarter of 2026.

Markets open original ↗

earnings

10:21
Google News: Tianqi Lithium

Tianqi Lithium Corporation (002466.SZ) issued a profit forecast, expecting net profit attributable to shareholders of RMB 2.85 billion to RMB 4.25 billion for the first half of the year, representing an increase of 3,276.35% to 4,934.91% year-on-year.

Tianqi Lithium issued a profit forecast projecting first-half net profit up roughly 3,276% to 4,935% year-on-year.

Markets open original ↗

earnings

10:07
Google News: JOINN Laboratories

Lab Monkey Prices Surge to 178,000 Yuan Each, Joinn Laboratories' First-Half Net Profit Soars Over 1,300%

Surging lab-monkey prices helped JOINN Laboratories' first-half net profit soar over 1,300%.

Markets open original ↗

regulation

10:00
Google News: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma

Kelun-Biotech and Harbour BioMed announced NMPA approval of an IND application for SKB575/HBM7575 to treat asthma.

Markets open original ↗

The wire

everything that arrived · 7 days